The challenge of blood pressure control in patients with ischaemic heart disease in Europe

References

• Hyman D. J., Pavlik V. N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479–486
   PubMed Web of Science ®Google Scholar
• Zdrojewski T., Szpakowski P., Bandosz P., Pajak A., Wiecek A., Krupa‐Wojciechowska B., et al. Arterial hypertension in Poland in 2002. J Hum Hypertens 2004; 18: 557–562
   PubMed Web of Science ®Google Scholar
• Maziak W., Keil U., Doring A., Hense H. W. Determinants of poor hypertension management in community. J Hum Hypertens 2003; 17: 215–217
   PubMed Web of Science ®Google Scholar
• Knight E. L., Bohn R. L., Wang P. S., Glynn R. J., Mogun H., Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38: 809–814
   PubMed Web of Science ®Google Scholar
• He J., Muntner P., Chen J., Roccella E. J., Streiffer R. H., Whelton P. K. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162: 1051–1058
   PubMedGoogle Scholar
• EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies on coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme., Eur Heart J. 22. 554–572
   Google Scholar
• Pearson T. A., Peters T. D., Feury D. Comprehensive risk reduction in coronary patients: Attainment of goals of the AHA Guidelines in U.S. patients. Circulation 1997; 96((8S))733–I
   PubMedGoogle Scholar
• EUROASPIRE Study Group: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J. 18. 1569–1582
   Google Scholar
• Kawecka‐Jaszcz K., Jankowski P., Pajak A., Dubiel J., Maciejewicz J., Piotrowski W., et al. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Part III: Secondary prevention of ischaemic heart disease after discharge. Przegl Lek 2001; 58: 964–968
   Google Scholar
• EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries., Lancet. 357. 995–1001
   Google Scholar
• Jankowski P., Kawecka‐Jaszcz K., Pajak A., Bilo G., Dubiel J. S., Maciejewicz J., et al. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Secondary prevention of ischaemic heart disease after discharge in 1997/98 and 1999/2000. Przegl Lek 2003; 60: 142–146
   Google Scholar
• Amar J., Chamontin B., Ferrieres J., Danchin N., Grenier O., Cantet C. Hypertension control at hospital discharge after acute coronary event: Influence on cardiovascular prognosis – The PREVENIR study. Heart 2002; 88: 587–591
   PubMed Web of Science ®Google Scholar
• Jankowski P., Kawecka‐Jaszcz K., Bilo G., Paja˛k A. Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press 2005; 14: 284–292
   PubMed Web of Science ®Google Scholar
• Amar J., Chamontin B., Genes N., Cantet C., Salvador M., Cambou J. P. Why is hypertension so frequently uncontrolled in secondary prevention?. J Hypertens 2003; 21: 1199–205
   PubMed Web of Science ®Google Scholar
• Kawecka‐Jaszcz K., Jankowski P., Paja˛k A. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol 2003; 91: 15–23
   PubMed Web of Science ®Google Scholar
• Kawecka‐Jaszcz K., Jankowski P., Paja˛k A., et al. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Secondary prevention of ischaemic heart disease during hospitalisation in 1996/1997 and 1998/1999. Eur Heart J Suppl 2004; 6(Suppl J)J47–J52
   Google Scholar
• Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560–2572
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. 2003 European Society of Hypertension‐European Society of Cardiology guidelines for the management of arterial hypertension., J Hypertens. 21. 1011–1053
   Google Scholar
• Boersma E., Keil U., De Bacquer D., et al. Blood pressure is insufficiently controlled in European patients with established coronary artery disease. J Hypertens 2003; 21: 1831–1840
   PubMed Web of Science ®Google Scholar
• De Macedo C. R., Noblat A. C., Noblat L., de Macedo J. M., Lopes A. A. Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients. Arq Bras Cardiol 2001; 77: 328–331
   Google Scholar
• Berlowitz D. R., Ash A. S., Hickey E. C., Friedman R. H., Glickman M., Kader B., et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–1963
   PubMed Web of Science ®Google Scholar
• 27th Bethesda Conference. Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events., J Am Coll Cardiol. 27. 957–1047
   Google Scholar
• Hyman D. J., Pavlik V. N. Self‐reported hypertension treatment practices among primary care physicians. Blood pressure thresholds, drug choices, and the role of guidelines and evidence‐based medicine. Arch Intern Med 2000; 160: 2281–2286
   PubMed Web of Science ®Google Scholar
• Oliveria S. A., Lapuerta P., McCarthy B. D., L'Italien G. J., Berlowitz D. R., Asch S. M. Physician‐related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413–420
   PubMed Web of Science ®Google Scholar
• Jolly K., Bradley F., Sharp S., Smith H., Thompson S., Kinmonth A. L., et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton heart integrated care project (SHIP). BMJ 1999; 318: 706–711
   PubMed Web of Science ®Google Scholar
• Murchie P., Campbell N. C., Ritchie L. D., Simpson J. A., Thain J. Secondary prevention clinics for coronary heart disease: Four year follow up of a randomised controlled trial in primary care. BMJ 2003; 326: 84–90
   PubMed Web of Science ®Google Scholar
• Lear S. A., Ignaszewski A., Linden W., et al. The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J 2003; 24: 1920–1927
   PubMed Web of Science ®Google Scholar
• Tuniz D., Bernardi G., Molinis G., et al. Ambulatory cardiac rehabilitation with individualized care after elective coronary angioplasty: One year outcome. Eur Heart J Suppl 2004; 6(Suppl J)J37–J46
   Google Scholar
• Fox K., Barber K., Muir L., Mead A., Harris A., Collier T., et al. Development, implementation and audit of a cardiac prevention and rehabilitation programme for patients with coronary artery disease. Eur Heart J Suppl 2004; 6(Suppl J)J53–J58
   Google Scholar
• Wood D. A., Kotseva K., Jennings C., Mead A., Jones J., Holden A., et al. EuroAction: A European Society of Cardiology demonstration project in preventive cardiology. A cluster randomised controlled trial of a multi‐disciplinary preventive cardiology programme for coronary patients, asymptomatic high risk individuals and their families. Summary of design, methodology and outcomes. Eur Heart J Suppl 2004; 6(Suppl J)J3–J15
   Google Scholar
• De Backer G., Ambrosini E., Borch‐Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2003; 10(Suppl 1)S1–S78
   PubMedGoogle Scholar